You are here

New RFA: Genetic Engineering Technologies for HIV Cure Research

Tuesday, December 4, 2018

New RFA from NIAID and NIMH:

The purpose of this Funding Opportunity Announcement (FOA) is to apply genetic engineering technologies to HIV-1 cure research.  Gene- and/or cell-based approaches are sought that can achieve long-term remission of HIV-1 in the absence of antiretroviral treatment or complete elimination of HIV-1.  Applications are expected to include basic science/preclinical research as well as translational activities such as test-of-concept studies in animal models or human subjects and must be designed as collaborative efforts between academia and the private sector.

The RFA is published in the NIH Guide: